+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Generic Drugs Market, By Type (Small Molecule Generics vs Biosimilars), By Application (Cardiovascular Diseases, Diabetes, Neurology, Others), By Drug Delivery, By Form, By Source, By Distribution Channel, By Company, By Region, Forecast & Opportunities, 2026

  • ID: 5311298
  • Report
  • April 2021
  • Region: Global
  • 118 pages
  • TechSci Research
The Global Generic Drugs Market Was Valued at Usd371.04 Billion in 2020 and is Anticipated to Reach Usd564.43 Billion Until 2026 by Witnessing a CAGR of 7.08% During the Forecast Period.

FEATURED COMPANIES

  • Abbott Laboratories Inc.
  • Aurobindo Pharma Limited
  • Cipla Ltd.
  • Endo Pharmaceuticals Inc.
  • Fresenius Kabi AG
  • Lupin Limited
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Generic Drugs Market was valued at USD371.04 billion in 2020 and is anticipated to reach USD564.43 billion until 2026 by witnessing a CAGR of 7.08% during the forecast period. The Global Generic Drugs Market is driven by rising prevalence of chronic diseases across the globe. Moreover, availability of generic drugs at a lower cost and having the same chemical composition of branded drugs is one of the key factors which is positively impacting the growth of the market during the forecast period. Also, increasing count of drug patent expirations is further expected to bolster the growth of the market over the next few years.

The Global Generic Drugs Market is segmented based on type, application, drug delivery, form, source, distribution channel, company, and region. In terms of application, the market can be categorized into cardiovascular diseases, diabetes, neurology, oncology, anti-inflammatory diseases, others. Out of which, the cardiovascular diseases segment dominated the market by holding 35.05% market share in 2020 and the segment is expected to maintain its leading position in the market during the forecast period as well. This can be ascribed to majority of population dealing with cardiovascular diseases across the globe. On the contrary, the diabetes segment is anticipated to register the highest growth in the coming years which can be attributed to ever increasing prevalence of diabetes predominantly in Asia-Pacific region. Also, growing use of metformin generic drug for the treatment of diabetes owing to its effectiveness, is further contributing to the segmental growth.

The major players operating in the Global Generic Drugs Market are Teva Pharmaceutical Industries Ltd, Mylan NV, Sandoz International GmbH (Novartis AG), Lupin Limited, Pfizer Inc., Sun Pharmaceutical Industries Limited, Endo Pharmaceuticals Inc., Aurobindo Pharma Limited, Dr Reddy’s Laboratories Ltd., Fresenius Kabi AG, Aspen Pharmacare Holdings Limited, Sanofi S.A., Cipla Ltd., Novo Nordisk A/S, Abbott Laboratories Inc., and others. Major companies are developing advanced technologies and launching new products to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnership, agreements, and new developments in order to expand their geographic reach and to increase their customer base.

Years considered for this report:
  • Historical Years: 2016-2019
  • Base Year: 2020
  • Estimated Year: 2021
  • Forecast Period: 2022-2026
Objective of the Study:
  • To analyze historical growth in market size of the Global Generic Drugs Market from 2016 to 2019.
  • To estimate and forecast the market size of the Global Generic Drugs Market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast the Global Generic Drugs Market based on type, application, drug delivery, form, source, distribution channel, company and regional distribution.
  • To identify dominant region or segment in the Global Generic Drugs Market.
  • To identify drivers and challenges for the Global Generic Drugs Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Generic Drugs Market.
  • To conduct pricing analysis for the Global Generic Drugs Market.
  • To identify and analyze the profiles of leading players operating in the Global Generic Drugs Market.
  • To identify key sustainable strategies adopted by market players in the Global Generic Drugs Market.
The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of manufacturers across the globe. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the manufacturers which could not be identified due to the limitations of secondary research. The publisher analyzed the products and presence of all major players across the globe.

The publisher calculated the market size of the Global Generic Drugs Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:
  • Generic drugs manufacturers
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to generic drugs
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:

In this report, the Global Generic Drugs Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global Generic Drugs Market, By Type:
  • Small Molecule Generics
  • Biosimilars
Global Generic Drugs Market, By Application:
  • Cardiovascular Diseases
  • Diabetes
  • Neurology
  • Oncology
  • Anti-Inflammatory Diseases
  • Others
Global Generic Drugs Market, By Drug Delivery:
  • Oral
  • Topical
  • Parenteral
  • Others
Global Generic Drugs Market, By Form:
  • Tablet
  • Capsule
  • Injection
  • Others
Global Generic Drugs Market, By Source:
  • In House
  • Contract Manufacturing Organizations
Global Generic Drugs Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others
Global Generic Drugs Market, By Region:
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • South America
  • Brazil
  • Argentina
  • Colombia
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Generic Drugs Market.

Available Customizations:
With the given market data, the publisher offers customizations according to a client’s specific needs.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories Inc.
  • Aurobindo Pharma Limited
  • Cipla Ltd.
  • Endo Pharmaceuticals Inc.
  • Fresenius Kabi AG
  • Lupin Limited
1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Generic Drugs Market

4. Executive Summary

5. Voice of Customer
5.1. Brand Awareness
5.2. Factors driving Global Generic Drugs Market
5.3. Factors Influencing Drug Purchase Decision

6. Global Generic Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Small Molecule Generics vs Biosimilars)
6.2.2. By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others)
6.2.3. By Drug Delivery (Oral, Topical, Parenteral, Others)
6.2.4. By Form (Tablet, Capsule, Injection, Others)
6.2.5. By Source (In House vs Contract Manufacturing Organizations)
6.2.6. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others
6.2.7. By Region
6.2.8. By Company (2020)
6.3. Product Market Map

7. North America Generic Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Application
7.2.3. By Drug Delivery
7.2.4. By Form
7.2.5. By Source
7.2.6. By Distribution Channel
7.2.7. By Country (United States; Canada; Mexico)
7.3. North America: Country Analysis
7.3.1. United States Generic Drugs Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Application
7.3.1.2.3. By Drug Delivery
7.3.1.2.4. By Form
7.3.1.2.5. By Source
7.3.1.2.6. By Distribution Channel
7.3.2. Canada Generic Drugs Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Application
7.3.2.2.3. By Drug Delivery
7.3.2.2.4. By Form
7.3.2.2.5. By Source
7.3.2.2.6. By Distribution Channel
7.3.3. Mexico Generic Drugs Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Application
7.3.3.2.3. By Drug Delivery
7.3.3.2.4. By Form
7.3.3.2.5. By Source
7.3.3.2.6. By Distribution Channel

8. Europe Generic Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Application
8.2.3. By Drug Delivery
8.2.4. By Form
8.2.5. By Source
8.2.6. By Distribution Channel
8.2.7. By Country (France; Germany; UK; Italy; Spain)
8.3. Europe: Country Analysis
8.3.1. Germany Generic Drugs Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Application
8.3.1.2.3. By Drug Delivery
8.3.1.2.4. By Form
8.3.1.2.5. By Source
8.3.1.2.6. By Distribution Channel
8.3.2. France Generic Drugs Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Application
8.3.2.2.3. By Drug Delivery
8.3.2.2.4. By Form
8.3.2.2.5. By Source
8.3.2.2.6. By Distribution Channel
8.3.3. United Kingdom Generic Drugs Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Application
8.3.3.2.3. By Drug Delivery
8.3.3.2.4. By Form
8.3.3.2.5. By Source
8.3.3.2.6. By Distribution Channel
8.3.4. Italy Generic Drugs Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Application
8.3.4.2.3. By Drug Delivery
8.3.4.2.4. By Form
8.3.4.2.5. By Source
8.3.4.2.6. By Distribution Channel
8.3.5. Spain Generic Drugs Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Application
8.3.5.2.3. By Drug Delivery
8.3.5.2.4. By Form
8.3.5.2.5. By Source
8.3.5.2.6. By Distribution Channel

9. Asia-Pacific Generic Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Application
9.2.3. By Drug Delivery
9.2.4. By Form
9.2.5. By Source
9.2.6. By Distribution Channel
9.2.7. By Country (China; India; Japan; South Korea; Australia)
9.3. Asia-Pacific: Country Analysis
9.3.1. China Generic Drugs Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Application
9.3.1.2.3. By Drug Delivery
9.3.1.2.4. By Form
9.3.1.2.5. By Source
9.3.1.2.6. By Distribution Channel
9.3.2. India Generic Drugs Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Application
9.3.2.2.3. By Drug Delivery
9.3.2.2.4. By Form
9.3.2.2.5. By Source
9.3.2.2.6. By Distribution Channel
9.3.3. Australia Generic Drugs Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Application
9.3.3.2.3. By Drug Delivery
9.3.3.2.4. By Form
9.3.3.2.5. By Source
9.3.3.2.6. By Distribution Channel
9.3.4. South Korea Generic Drugs Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Type
9.3.4.2.2. By Application
9.3.4.2.3. By Drug Delivery
9.3.4.2.4. By Form
9.3.4.2.5. By Source
9.3.4.2.6. By Distribution Channel
9.3.5. Japan Generic Drugs Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Type
9.3.5.2.2. By Application
9.3.5.2.3. By Drug Delivery
9.3.5.2.4. By Form
9.3.5.2.5. By Source
9.3.5.2.6. By Distribution Channel

10. Middle East and Africa Generic Drugs Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Application
10.2.3. By Drug Delivery
10.2.4. By Form
10.2.5. By Source
10.2.6. By Distribution Channel
10.2.7. By Country (UAE; Saudi Arabia; South Africa)
10.3. MEA: Country Analysis
10.3.1. South Africa Generic Drugs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Application
10.3.1.2.3. By Drug Delivery
10.3.1.2.4. By Form
10.3.1.2.5. By Source
10.3.1.2.6. By Distribution Channel
10.3.2. Saudi Arabia Generic Drugs Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Application
10.3.2.2.3. By Drug Delivery
10.3.2.2.4. By Form
10.3.2.2.5. By Source
10.3.2.2.6. By Distribution Channel
10.3.3. UAE Generic Drugs Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Application
10.3.3.2.3. By Drug Delivery
10.3.3.2.4. By Form
10.3.3.2.5. By Source
10.3.3.2.6. By Distribution Channel

11. South America Generic Drugs Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Type
11.2.2. By Application
11.2.3. By Drug Delivery
11.2.4. By Form
11.2.5. By Source
11.2.6. By Distribution Channel
11.2.7. By Country (Brazil; Argentina; Colombia)
11.3. South America: Country Analysis
11.3.1. Brazil Generic Drugs Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Type
11.3.1.2.2. By Application
11.3.1.2.3. By Drug Delivery
11.3.1.2.4. By Form
11.3.1.2.5. By Source
11.3.1.2.6. By Distribution Channel
11.3.2. Argentina Generic Drugs Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Type
11.3.2.2.2. By Application
11.3.2.2.3. By Drug Delivery
11.3.2.2.4. By Form
11.3.2.2.5. By Source
11.3.2.2.6. By Distribution Channel
11.3.3. Colombia Generic Drugs Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Type
11.3.3.2.2. By Application
11.3.3.2.3. By Drug Delivery
11.3.3.2.4. By Form
11.3.3.2.5. By Source
11.3.3.2.6. By Distribution Channel

12. Market Dynamics
12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape
14.1. Competition Outlook
14.2. Company Profiles
14.2.1. Teva Pharmaceutical Industries Ltd.
14.2.2. Mylan NV
14.2.3. Sandoz International GmbH (Novartis AG)
14.2.4. Lupin Limited
14.2.5. Pfizer Inc.
14.2.6. Sun Pharmaceutical Industries Limited
14.2.7. Endo Pharmaceuticals Inc.
14.2.8. Aurobindo Pharma Limited
14.2.9. Dr Reddy’s Laboratories Ltd.
14.2.10. Fresenius Kabi AG
14.2.11. Aspen Pharmacare Holdings Limited
14.2.12. Sanofi SA
14.2.13. Cipla Ltd.
14.2.14. Novo Nordisk A/S
14.2.15. Abbott Laboratories Inc.

15. Strategic Recommendations

16. About the Publisher and Disclaimer

List of Figures
Figure 1: Global Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 2: Global Generic Drugs Market Share, By Type, 2016-2026F
Figure 3: Global Generic Drugs Market Share, By Application, 2016-2026F
Figure 4: Global Generic Drugs Market Share, By Drug Delivery, 2016-2026F
Figure 5: Global Generic Drugs Market Share, By Form, 2016-2026F
Figure 6: Global Generic Drugs Market Share, By Source, 2016-2026F
Figure 7: Global Generic Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 8: Global Generic Drugs Market Share, By Company, 2016-2026F
Figure 9: Global Generic Drugs Market Share, By Region, 2016-2026F
Figure 10: Global Generic Drugs Product Market Map, By Region, By Value, 2016-2026F
Figure 11: North America Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 12: North America Generic Drugs Market Share, By Type, 2016-2026F
Figure 13: North America Generic Drugs Market Share, By Application, 2016-2026F
Figure 14: North America Generic Drugs Market Share, By Drug Delivery, 2016-2026F
Figure 15: North America Generic Drugs Market Share, By Form, 2016-2026F
Figure 16: North America Generic Drugs Market Share, By Source, 2016-2026F
Figure 17: North America Generic Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 18: North America Generic Drugs Market Share, By Country, 2016-2026F
Figure 19: United States Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 20: United States Generic Drugs Market Share, By Type, 2016-2026F
Figure 21: United States Generic Drugs Market Share, By Application, 2016-2026F
Figure 22: United States Generic Drugs Market Share, By Drug Delivery, 2016-2026F
Figure 23: United States Generic Drugs Market Share, By Form, 2016-2026F
Figure 24: United States Generic Drugs Market Share, By Source, 2016-2026F
Figure 25: United States Generic Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 26: Canada Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 27: Canada Generic Drugs Market Share, By Type, 2016-2026F
Figure 28: Canada Generic Drugs Market Share, By Application, 2016-2026F
Figure 29: Canada Generic Drugs Market Share, By Drug Delivery, 2016-2026F
Figure 30: Canada Generic Drugs Market Share, By Form, 2016-2026F
Figure 31: Canada Generic Drugs Market Share, By Source, 2016-2026F
Figure 32: Canada Generic Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 33: Mexico Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 34: Mexico Generic Drugs Market Share, By Type, 2016-2026F
Figure 35: Mexico Generic Drugs Market Share, By Application, 2016-2026F
Figure 36: Mexico Generic Drugs Market Share, By Drug Delivery, 2016-2026F
Figure 37: Mexico Generic Drugs Market Share, By Form, 2016-2026F
Figure 38: Mexico Generic Drugs Market Share, By Source, 2016-2026F
Figure 39: Mexico Generic Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 40: Europe Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 41: Europe Generic Drugs Market Share, By Type, 2016-2026F
Figure 42: Europe Generic Drugs Market Share, By Application, 2016-2026F
Figure 43: Europe Generic Drugs Market Share, By Drug Delivery, 2016-2026F
Figure 44: Europe Generic Drugs Market Share, By Form, 2016-2026F
Figure 45: Europe Generic Drugs Market Share, By Source, 2016-2026F
Figure 46: Europe Generic Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 47: Europe Generic Drugs Market Share, By Country, 2016-2026F
Figure 48: Germany Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 49: Germany Generic Drugs Market Share, By Type, 2016-2026F
Figure 50: Germany Generic Drugs Market Share, By Application, 2016-2026F
Figure 51: Germany Generic Drugs Market Share, By Drug Delivery, 2016-2026F
Figure 52: Germany Generic Drugs Market Share, By Form, 2016-2026F
Figure 53: Germany Generic Drugs Market Share, By Source, 2016-2026F
Figure 54: Germany Generic Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 55: France Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 56: France Generic Drugs Market Share, By Type, 2016-2026F
Figure 57: France Generic Drugs Market Share, By Application, 2016-2026F
Figure 58: France Generic Drugs Market Share, By Drug Delivery, 2016-2026F
Figure 59: France Generic Drugs Market Share, By Form, 2016-2026F
Figure 60: France Generic Drugs Market Share, By Source, 2016-2026F
Figure 61: France Generic Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 62: United Kingdom Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 63: United Kingdom Generic Drugs Market Share, By Type, 2016-2026F
Figure 64: United Kingdom Generic Drugs Market Share, By Application, 2016-2026F
Figure 65: United Kingdom Generic Drugs Market Share, By Drug Delivery, 2016-2026F
Figure 66: United Kingdom Generic Drugs Market Share, By Form, 2016-2026F
Figure 67: United Kingdom Generic Drugs Market Share, By Source, 2016-2026F
Figure 68: United Kingdom Generic Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 69: Italy Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 70: Italy Generic Drugs Market Share, By Type, 2016-2026F
Figure 71: Italy Generic Drugs Market Share, By Application, 2016-2026F
Figure 72: Italy Generic Drugs Market Share, By Drug Delivery, 2016-2026F
Figure 73: Italy Generic Drugs Market Share, By Form, 2016-2026F
Figure 74: Italy Generic Drugs Market Share, By Source, 2016-2026F
Figure 75: Italy Generic Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 76: Spain Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 77: Spain Generic Drugs Market Share, By Type, 2016-2026F
Figure 78: Spain Generic Drugs Market Share, By Application, 2016-2026F
Figure 79: Spain Generic Drugs Market Share, By Drug Delivery, 2016-2026F
Figure 80: Spain Generic Drugs Market Share, By Form, 2016-2026F
Figure 81: Spain Generic Drugs Market Share, By Source, 2016-2026F
Figure 82: Spain Generic Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 83: Asia Pacific Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 84: Asia Pacific Generic Drugs Market Share, By Type, 2016-2026F
Figure 85: Asia Pacific Generic Drugs Market Share, By Application, 2016-2026F
Figure 86: Asia Pacific Generic Drugs Market Share, By Drug Delivery, 2016-2026F
Figure 87: Asia Pacific Generic Drugs Market Share, By Form, 2016-2026F
Figure 88: Asia Pacific Generic Drugs Market Share, By Source, 2016-2026F
Figure 89: Asia Pacific Generic Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 90: Asia Pacific Generic Drugs Market Share, By Country, 2016-2026F
Figure 91: China Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 92: China Generic Drugs Market Share, By Type, 2016-2026F
Figure 93: China Generic Drugs Market Share, By Application, 2016-2026F
Figure 94: China Generic Drugs Market Share, By Drug Delivery, 2016-2026F
Figure 95: China Generic Drugs Market Share, By Form, 2016-2026F
Figure 96: China Generic Drugs Market Share, By Source, 2016-2026F
Figure 97: China Generic Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 98: India Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 99: India Generic Drugs Market Share, By Type, 2016-2026F
Figure 100: India Generic Drugs Market Share, By Application, 2016-2026F
Figure 101: India Generic Drugs Market Share, By Drug Delivery, 2016-2026F
Figure 102: India Generic Drugs Market Share, By Form, 2016-2026F
Figure 103: India Generic Drugs Market Share, By Source, 2016-2026F
Figure 104: India Generic Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 105: Australia Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 106: Australia Generic Drugs Market Share, By Type, 2016-2026F
Figure 107: Australia Generic Drugs Market Share, By Application, 2016-2026F
Figure 108: Australia Generic Drugs Market Share, By Drug Delivery, 2016-2026F
Figure 109: Australia Generic Drugs Market Share, By Form, 2016-2026F
Figure 110: Australia Generic Drugs Market Share, By Source, 2016-2026F
Figure 111: Australia Generic Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 112: South Korea Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 113: South Korea Generic Drugs Market Share, By Type, 2016-2026F
Figure 114: South Korea Generic Drugs Market Share, By Application, 2016-2026F
Figure 115: South Korea Generic Drugs Market Share, By Drug Delivery, 2016-2026F
Figure 116: South Korea Generic Drugs Market Share, By Form, 2016-2026F
Figure 117: South Korea Generic Drugs Market Share, By Source, 2016-2026F
Figure 118: South Korea Generic Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 119: Japan Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 120: Japan Generic Drugs Market Share, By Type, 2016-2026F
Figure 121: Japan Generic Drugs Market Share, By Application, 2016-2026F
Figure 122: Japan Generic Drugs Market Share, By Drug Delivery, 2016-2026F
Figure 123: Japan Generic Drugs Market Share, By Form, 2016-2026F
Figure 124: Japan Generic Drugs Market Share, By Source, 2016-2026F
Figure 125: Japan Generic Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 126: South America Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 127: South America Generic Drugs Market Share, By Type, 2016-2026F
Figure 128: South America Generic Drugs Market Share, By Application, 2016-2026F
Figure 129: South America Generic Drugs Market Share, By Drug Delivery, 2016-2026F
Figure 130: South America Generic Drugs Market Share, By Form, 2016-2026F
Figure 131: South America Generic Drugs Market Share, By Source, 2016-2026F
Figure 132: South America Generic Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 133: South America Generic Drugs Market Share, By Country, 2016-2026F
Figure 134: Brazil Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 135: Brazil Generic Drugs Market Share, By Type, 2016-2026F
Figure 136: Brazil Generic Drugs Market Share, By Application, 2016-2026F
Figure 137: Brazil Generic Drugs Market Share, By Drug Delivery, 2016-2026F
Figure 138: Brazil Generic Drugs Market Share, By Form, 2016-2026F
Figure 139: Brazil Generic Drugs Market Share, By Source, 2016-2026F
Figure 140: Brazil Generic Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 141: Argentina Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 142: Argentina Generic Drugs Market Share, By Type, 2016-2026F
Figure 143: Argentina Generic Drugs Market Share, By Application, 2016-2026F
Figure 144: Argentina Generic Drugs Market Share, By Drug Delivery, 2016-2026F
Figure 145: Argentina Generic Drugs Market Share, By Form, 2016-2026F
Figure 146: Argentina Generic Drugs Market Share, By Source, 2016-2026F
Figure 147: Argentina Generic Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 148: Colombia Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 149: Colombia Generic Drugs Market Share, By Type, 2016-2026F
Figure 150: Colombia Generic Drugs Market Share, By Application, 2016-2026F
Figure 151: Colombia Generic Drugs Market Share, By Drug Delivery, 2016-2026F
Figure 152: Colombia Generic Drugs Market Share, By Form, 2016-2026F
Figure 153: Colombia Generic Drugs Market Share, By Source, 2016-2026F
Figure 154: Colombia Generic Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 155: Middle East & Africa Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 156: Middle East & Africa Generic Drugs Market Share, By Type, 2016-2026F
Figure 157: Middle East & Africa Generic Drugs Market Share, By Application, 2016-2026F
Figure 158: Middle East & Africa Generic Drugs Market Share, By Drug Delivery, 2016-2026F
Figure 159: Middle East & Africa Generic Drugs Market Share, By Form, 2016-2026F
Figure 160: Middle East & Africa Generic Drugs Market Share, By Source, 2016-2026F
Figure 161: Middle East & Africa Generic Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 162: Middle East & Africa Generic Drugs Market Share, By Country, 2016-2026F
Figure 163: South Africa Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 164: South Africa Generic Drugs Market Share, By Type, 2016-2026F
Figure 165: South Africa Generic Drugs Market Share, By Application, 2016-2026F
Figure 166: South Africa Generic Drugs Market Share, By Drug Delivery, 2016-2026F
Figure 167: South Africa Generic Drugs Market Share, By Form, 2016-2026F
Figure 168: South Africa Generic Drugs Market Share, By Source, 2016-2026F
Figure 169: South Africa Generic Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 170: Saudi Arabia Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 171: Saudi Arabia Generic Drugs Market Share, By Type, 2016-2026F
Figure 172: Saudi Arabia Generic Drugs Market Share, By Application, 2016-2026F
Figure 173: Saudi Arabia Generic Drugs Market Share, By Drug Delivery, 2016-2026F
Figure 174: Saudi Arabia Generic Drugs Market Share, By Form, 2016-2026F
Figure 175: Saudi Arabia Generic Drugs Market Share, By Source, 2016-2026F
Figure 176: Saudi Arabia Generic Drugs Market Share, By Distribution Channel, 2016-2026F
Figure 180: UAE Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
Figure 181: UAE Generic Drugs Market Share, By Type, 2016-2026F
Figure 182: UAE Generic Drugs Market Share, By Application, 2016-2026F
Figure 183: UAE Generic Drugs Market Share, By Drug Delivery, 2016-2026F
Figure 184: UAE Generic Drugs Market Share, By Form, 2016-2026F
Figure 185: UAE Generic Drugs Market Share, By Source, 2016-2026F
Figure 186: UAE Generic Drugs Market Share, By Distribution Channel, 2016-2026F
Note: Product cover images may vary from those shown
  • Teva Pharmaceutical Industries Ltd.
  • Mylan NV
  • Sandoz International GmbH (Novartis AG)
  • Lupin Limited
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Limited
  • Endo Pharmaceuticals Inc.
  • Aurobindo Pharma Limited
  • Dr Reddy’s Laboratories Ltd.
  • Fresenius Kabi AG
  • Aspen Pharmacare Holdings Limited
  • Sanofi SA
  • Cipla Ltd.
  • Novo Nordisk A/S
  • Abbott Laboratories Inc.
Note: Product cover images may vary from those shown
Adroll
adroll